Peter A. Brooke has been called “the Johnny Appleseed of venture capital.” The chairman and founder of Advent International and TA Associates, Brooke is one of the pioneers of the venture industry in New England and the first to successfully introduce venture capital and private equity globally.

At the age of 80, he remains one of the leading experts on how venture and private equity are playing out on the global stage. His forthcoming book, A Vision for Venture Capital, written with Daniel Penrice, chronicles his storied career in venture capital and private equity and provides fresh perspective on the industry’s evolution and how it can fulfill ambitions of helping grow the world’s economies in the twenty-first century.

Mr. Brooke will sit down for an unprecedented one-on-one chat with another of New England’s venture capital all-stars, Polaris Venture Partners co-founder and managing director Terry McGuire, who is also chairman of the National Venture Capital Association.

Their intimate discussion will cover the origins of New England venture capital and its trials and tribulations through boom times and downturns—and then look more broadly at the current and future outlook for private equity and its role in worldwide economic growth.

Is the venture capital model really broken? Are financial markets in need of much more regulation? And how can private equity help pull the world out of recession and stave off future downturns?  Nobody who cares about these sorts of questions should miss this up-close-and-personal conversation.

Schedule:
Registration: 5:15 – 6:00 pm
Program: 6:00 – 7:00 pm
Networking reception: 7:00 – 8:00 pm

Registration information:
Tickets are transferable but not refundable.
To inquire about press registration, e-mail events@xconomy.com.

Peter Brooke, Chairman of Advent International, has over 40 years of banking and venture capital experience in the U.S., Europe, Asia and other international markets.

He founded Advent in 1984 as the successor to TA Associates in the management of international private equity investment programs. In addition to serving as CEO of Advent for 11 years, he helped establish numerous affiliated venture capital and private equity firms in Europe, Asia, Latin America, and Israel. During his tenure, Advent expanded significantly and today is one of the world’s leading global private equity firms, with offices in 16 countries and $24 billion in cumulative capital raised.

Prior to forming Advent, Peter was the managing partner of TA Associates, a Boston-based private equity firm he founded in 1968. From 1963 to 1968, Peter worked for the investment banking firm of Tucker, Anthony & RL Day, where he was in charge of its corporate finance and venture capital activities. Earlier, he was head of the venture capital department of Bessemer Securities. He began his career as a lending officer at the First National Bank of Boston, where he founded the High Technology Lending Group.

Peter is a member of the Private Equity Hall of Fame and recipient of the National Venture Capital Association's Lifetime Achievement in Venture Capital Award and Harvard Business School's Alumni Achievement Award. The Boston Business Journal named him one of Greater Boston's 100 most influential business people of the 20th century. He is a Fellow of the American Academy of Arts and Sciences and a member of the Board of Trustees of the Boston Symphony Orchestra.

Peter is a graduate of Harvard University and Harvard Business School.

Terry McGuire is a co-founder and general partner of Polaris Venture Partners based in the Boston office. Terry focuses on life sciences investments. He is currently Chairman of the National Venture Capital Association, which represents 90 percent of the venture capitalists in the United States.

Prior to starting Polaris, Terry spent seven years at Burr, Egan, Deleage & Co. investing in early stage medical and information technology companies. Terry began his career in venture capital at Golder, Thoma and Cressey in Chicago.

Terry has co-founded three companies: Inspire Pharmaceuticals, AIR (Advanced Inhalation Research, Inc.), and MicroCHIPS. He represents Polaris on the boards of directors of Acceleron Pharma, Adimab, Arsenal Medical, Inc., Cerulean Pharma Inc., Ironwood Pharmaceuticals, Life Line Screening, MicroCHIPS, Inc., Pulmatrix Inc., and Trevena Inc. He has previously served on the boards of Akamai, Aspect Medical Systems, Cubist Pharmaceuticals, deCODE Genetics, GlycoFi, Transform Pharmaceuticals, and Remon Medical Technologies.

In addition, Terry serves on the boards of the Thayer School of Engineering, Dartmouth College (Chair), MIT’s The David H. Koch Institute for Integrative Cancer Research, and The Arthur Rock Center for Entrepreneurship at HBS.

Terry has an MBA degree from Harvard Business School, an MS in engineering from The Thayer School at Dartmouth College, and a BS in physics and economics from Hobart College. He is a recipient of the Albert Einstein Award for Outstanding Achievement in the Life Sciences, awarded by Forbes/Gottlieb Medical Technology Investor, Harvard MIT Biomedical Engineering Center, the New Jerusalem Foundation, the Jerusalem Development Authority, and Rodman and Renshaw.